Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer

Abstract Tamoxifen-based endocrine therapy remains a major adjuvant therapy for estrogen receptor (ER)-positive breast cancer (BC). However, many patients develop tamoxifen resistance, which results in recurrence and poor prognosis. Herein, we show that fatty acid oxidation (FAO) was activated in ta...

Full description

Bibliographic Details
Main Authors: Cen Jiang, Youzhi Zhu, Huaying Chen, Junyu Lin, Ruiwang Xie, Weiwei Li, Jiajie Xue, Ling Chen, Xiangjin Chen, Sunwang Xu
Format: Article
Language:English
Published: Nature Publishing Group 2023-10-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06181-5

Internet

https://doi.org/10.1038/s41419-023-06181-5

Similar Items